How long does it take to see results on Wegovy?

The decision you're really making: patience or expectation-setting?

A question our prescribers hear most weeks is some version of: "I've been on Wegovy for a month and I've only lost a few pounds — is something wrong?" The short answer is almost always no. The longer answer is that Wegovy is designed to work across months, not days, and the titration schedule is the reason why.

Treatment starts at 0.25mg, a tolerability dose whose job is to acclimatise your system to semaglutide. The appetite-suppressing effect at that level is modest. As the dose steps up (0.5mg, then 1.0mg, 1.7mg, and eventually 2.4mg) the clinical effect builds. Most people reach the 2.4mg maintenance dose after about 16 to 20 weeks. Weight loss tracks that curve: gradual in the early weeks, more pronounced once the higher doses are sustained. Reviewing your results against the first four weeks is a bit like judging a marathon by the first mile.

The STEP 1 trial, published in the New England Journal of Medicine, followed adults with obesity over 68 weeks and found an average body-weight reduction of around 15% at 2.4mg. That figure reflects the full treatment period, not the early weeks. If you want to understand how long it takes to see results on Wegovy, that distinction matters when you're deciding whether to stay the course.

You can read more about the broader picture of Wegovy results, including what the evidence says about who tends to respond well.

When weight on the scales lags behind what's actually changing

Scales measure one thing. The physiological changes that precede visible weight loss (reduced appetite, slower gastric emptying, shifts in how the body processes food) begin earlier than the numbers suggest. Many people notice they feel full sooner, eat smaller portions without trying, or stop thinking about food between meals within the first two weeks. Those changes are the mechanism working.

What muddies the picture is that semaglutide, like all GLP-1 receptor agonists, also affects fluid balance and muscle retention during rapid weight loss. So the number on the scale at week four may undercount total fat loss, or may temporarily stall as lean tissue and hydration fluctuate. This is not a failure of the medicine; it's normal physiology during weight loss, and it's why clinicians prefer to assess progress over months, not weeks.

Lifestyle factors run alongside this. NHS guidance on semaglutide is clear that Wegovy is licensed for use alongside a reduced-calorie diet and increased physical activity, not instead of them. People who make modest dietary changes alongside treatment tend to see faster and more sustained results than those who rely on the medicine alone.

If you're weighing up timelines across different treatments, the semaglutide results timeline page covers the data in more detail.

The six-month marker: what NICE says and what it means for you

NICE's recommendation for semaglutide (Wegovy) includes a review point: if a patient has not lost at least 5% of their starting body weight after six months at the maintenance dose, the guidance suggests the prescriber reassesses whether continuing treatment is appropriate. This is not a threat or a deadline, it is a clinical checkpoint designed to protect patients from continuing a treatment that is not working for them.

In practice, this matters for two reasons. First, it tells you that six months is the minimum horizon for a fair assessment of whether Wegovy is working for you. Second, it means your prescriber needs to know how treatment is going, not just at that checkpoint, but throughout. At nume, every repeat order goes through a clinical re-review; there are no automatic refills. That means a prescriber is looking at your progress at each stage, not just ticking a box.

The 5% threshold at six months is also roughly aligned with when patients report meaningful improvements in quality of life, blood pressure, and other markers, which is why it has become the benchmark in UK clinical guidance.

If you are thinking about what treatment might cost over that kind of timeline, the Wegovy price page sets out the honest context. And if you want to explore how Wegovy fits into the broader range of options, our weight-loss treatment overview covers what is currently available.

What slows results down, and what tends to speed them up

A few factors genuinely affect how quickly you see results on Wegovy. Starting BMI plays a role: people with a higher starting weight often see larger absolute losses in the early weeks, though percentage weight loss tends to even out over time. Dose tolerance matters too, if side effects mean your prescriber keeps you at a lower dose for longer, the timeline extends.

Protein intake, hydration, and regular movement support the process. Semaglutide reduces appetite significantly; that is the point. But eating too little protein while losing weight rapidly can mean the body breaks down muscle alongside fat, which affects both how you feel and longer-term metabolic health. Practical things help: keeping meals structured, staying hydrated, building walking or resistance exercise into your week.

Alcohol and certain medicines can interact with how well Wegovy works, worth discussing with your prescriber at consultation. Oral contraceptives are not specifically flagged for Wegovy the way they are for tirzepatide, but your prescriber will review your full medicine list regardless.

If you have specific questions about how long before you see results on Wegovy, that page goes deeper into what to realistically expect at each stage of treatment. For a full clinical overview of the medicine itself, our Wegovy page is a good starting point.

If Wegovy sounds like it might suit you, the right next step is speaking to a prescriber who can assess your history properly. Start your free consultation and a GPhC-registered prescriber at our pharmacy will review your case the same day.